Indian Army Department Of Military Affairs Medical Supplies Tender India 2026 – ISI/AAA-TRTL Battery, Paracetamol, Pantoprazole & Multivitamins Procurement

Tender Overview

The procurement is for the Indian Army, Department Of Military Affairs, covering a broad range of medical consumables and Duracell batteries, including injections, tablets, syrups, vitamins, minerals, and battery cells. Estimated value and start/end dates are not disclosed; 40 BOQ items are listed, though many are marked N/A. The scope spans essential medicines (analgesics, antiemetics, antacids, antibiotics, antifungals), nutritional supplements (multivitamins, zinc, calcium+D3, Protinex), and Duracell AAA/AA batteries. This tender requires compliance with buyer-specified delivery terms and option clauses enabling quantity adjustments up to 25%, with delivery timelines linked to the original delivery period. The bid environment emphasizes vendor credentialing (PAN, GST, bank EFT mandate), and vendor code creation requirements. A mix of routine pharmaceutical and consumer health items alongside hardware batteries indicates a mass-consumption medical supply contract rather than a single-product line.

Technical Specifications & Requirements

• Product categories include: Inj (vaccines/tonic equivalents in 0.5 ml single-dose vials), Paracetamol infusions (100 ml), Neurobion vitamins, common cold tablets, Becosules, Ciprofloxacin-related tablets, Pantoprazole with Domperidone, Levocetirizine, Fexofenadine, Calcium with Vitamin D3, Zincovit, Antacid tablets, Dexamethasone, Omeprazole with Domperidone, Naproxen, Acetazolamide, Itraconazole, Ofloxacin+Ornidazole syrup (60 ml), Montelukast with Levocetirizine, Bromhexine syrup (100 ml), Dextromethorphan syrup (100 ml), mouth ulcer gel, multivitamin drops, Domperidone syrup, Alkasol, cough lozenges, glucose powder, Protinex powder, Accu-check strips, permethrin, gabafix, Ketoconazole shampoo, paraffin gauze, Diclofenac spray, Carboxy methyl cellulose eye drops, povidone iodine, Duracell batteries, Levosalbutamol, Budesonide.
• No explicit specifications or performance parameters are provided in the tender data. Delivery and quantity options are governed by the option clause; delivery time adjustments are calculated as (additional quantity/original quantity) × original delivery period, with a minimum of 30 days. EMD/price specifics, units, and quality standards are not specified in the available data.
• Compliance expectations include vendor code creation and banking/registration documents. Documentation must include PAN, GSTIN, cancelled cheque, and EFT mandate; no specific drug/formulation standards or GMP/ISO codes are listed in the data.

Terms, Conditions & Eligibility

• Option Clause: Purchaser may adjust quantity by ±25% at contract placement and during currency, at contracted rates; extended delivery time is determined by a formula with a 30-day minimum.
• Submission documents: PAN card copy, GSTIN copy, cancelled cheque, EFT mandate copy duly certified by bank.
• EMD/Performance terms are not numerically specified in the data; bidders must comply with the option clause and provide the listed documents to participate. No explicit warranty, penalties, or delivery penalties are described in the information provided. Vendors should prepare for standard government bid submissions and banking verifications as part of vendor code creation.